ArticleFrontiers in cell and developmental biology2025
Metabolic subtyping reveals PDIK1L as a dual-functional regulator of progression and PARP inhibitor sensitivity in prostate cancer.
Zhongyuan Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.